C07C 233/26
Having the carbon atom of the carboxamide group bound to an acyclic
Official title: having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a saturated carbon skeleton containing rings
C07C233/26 (Having the carbon atom of the carboxamide group bound to an acyclic) appears on 30 US grants and 33 published applications in this corpus.
Search patents in C07C- Granted patents
- 30
- Published applications
- 33
- Assignees
- 23
- Inventors
- 105
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 2 | 2 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 2 | 3 |
| 2016 | 0 | 3 |
| 2017 | 2 | 4 |
| 2018 | 2 | 3 |
| 2019 | 2 | 2 |
| 2020 | 3 | 1 |
| 2021 | 1 | 0 |
| 2022 | 1 | 2 |
| 2023 | 1 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Inhibitors of dihydroceramide desaturase for treating disease3 Oct 2023US 11,771,684 B2Centaurus Therapeutics
- Lipid nanoparticle composition18 Oct 2022US 11,472,766 B2Suzhou Abogen Biosciences Co., Ltd.
- Inhibitors of dihydroceramide desaturase for treating disease5 Oct 2021US 11,135,207 B2Centaurus Therapeutics
- N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress22 Dec 2020US 10,869,846 B2Sentient Lifesciences, Inc.
- Novel flavor compounds9 Jul 2026US 2026/0191244 A1International Flavors & Fragrances Inc.
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Lipid nanoparticle composition14 Sep 2023US 2023/0286902 A1Suzhou Abogen Biosciences Co., Ltd.
- Fabp4/5 inhibitors, methods of use and methods of making18 May 2023US 2023/0150931 A1Novius Therapeutics, LLC
- Lipid nanoparticle composition19 May 2022US 2022/0153686 A1Suzhou Abogen Biosciences Co., Ltd.
Most cited
By later US patents
- Aniline derivatives35US 7,879,863 B2Ajinomoto Co., Inc. · 2011
- Adamantane derivatives20US 6,242,470 B1AstraZeneca AB · 2001
- N-acetylcysteine amide (NAC amide) in the treatment of diseases and conditions associated with oxidative stress15US 9,216,162 B22015
- Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses11US 5,614,550 ASankyo Company, Limited · 1997
- N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress10US 8,993,627 B2Sentient Lifesciences, Inc. · 2015